Genetics |
|
|
Brain |
▸ MRI to identify presence of tubers, subependymal nodules, migrational defects and SEGA ▸ Screen for TAND ▸ Educate parents on infantile spasms during infancy ▸ Perform baseline EEG; if abnormal, follow-up with 24-hour video EEG to assess for subclinical seizure activity
|
▸ MRI every 1–3 years if asymptomatic and aged <25 years; more frequent MRIs in asymptomatic patients with large or growing SEGAs ▸ Screen for TAND annually; comprehensive formal TAND evaluation at key developmental time points (particularly at 0–3, 3–6, 6–9, 12–16 and 18–25 years) ▸ Routine EEG in patients with known or suspected seizure activity
|
Kidney |
▸ MRI of the abdomen to identify angiomyolipoma and renal cysts ▸ Measure BP to screen for hypertension ▸ Measure GFR to assess renal function
|
|
Lung |
▸ Baseline pulmonary function testing, 6-minute walk test and HRCT if at risk for LAM (typically women ≥18 years) ▸ Counsel on smoking risks and oestrogen use
|
▸ Clinical screening for LAM (ie, exertional dyspnoea) symptoms at each clinic visit ▸ Ongoing counselling on smoking risks and oestrogen use for patients at risk for LAM ▸ HRCT every 5–10 years in absence of lung cysts at baseline scan or every 2–3 years if lung cysts present ▸ Pulmonary function testing and 6-minute walk test annually if lung cysts present at baseline
|
Heart |
▸ ECG in all ages to identify underlying conduction defects ▸ Echocardiography in patients ≤3 years ▸ If rhabdomyomas are identified via prenatal ultrasound, consider fetal echocardiography after delivery to assess risk for heart failure
|
▸ ECG every 3–5 years in all ages if asymptomatic ▸ Echocardiography every 1–3 years in asymptomatic paediatric patients until cardiac rhabdomyomas regress ▸ Might necessitate more frequent or advanced diagnostics for symptomatic patients
|
Skin |
|
|
Teeth |
|
|
Eye |
|
|